Search alternatives:
values decrease » values increased (Expand Search), largest decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
when decrease » we decrease (Expand Search), mean decrease (Expand Search), nn decrease (Expand Search)
i when » _ when (Expand Search)
values decrease » values increased (Expand Search), largest decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
when decrease » we decrease (Expand Search), mean decrease (Expand Search), nn decrease (Expand Search)
i when » _ when (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
Trypanosome locomotion with a decreased body stiffness of , which leads to an increase in both the swimming velocity and rotation frequency when compared to the reference case in S1V.
Published 2025“…<p>Trypanosome locomotion with a decreased body stiffness of , which leads to an increase in both the swimming velocity and rotation frequency when compared to the reference case in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1013111#pcbi.1013111.s003" target="_blank">S1V</a>.…”
-
16
S1 File -
Published 2024“…Extent of the lesion of more than 75% was independently associated with day-60 mortality (aHR = 1.72[1.06; 2.78], p = 0.03). The prediction of death at day 60 was improved when considering simultaneously biological and radiological markers obtained on ICU admission (AUC = 0.78).…”
-
17
The capture efficiency of BioMagnetic solutions FerroSelect in PBS/1% BSA and whole blood showed a decrease in capture efficiency when moving to whole blood.
Published 2025“…<p>The capture efficiency of BioMagnetic solutions FerroSelect in PBS/1% BSA and whole blood showed a decrease in capture efficiency when moving to whole blood.…”
-
18
Budget impact model of acellular tissue engineered vessel for the repair of extremity arterial trauma when autologous vein is not feasible
Published 2025“…(acellular tissue engineered vessel-tyod [ATEV]) for extremity arterial trauma repair when autologous vein repair is not feasible.</p> <p>The 3-year budget impact of adding ATEV as a repair option alongside autologous vein, prosthetic graft, and “non-autologous other” grafts was evaluated from the perspectives of a Level I trauma center and third-party commercial payers. …”
-
19
-
20